IDO1 and cancer: The amino acid L-tryptophan (Trp) can be degraded to L-kynurenine (Kyn) catalyzed by IDO, which has a suppressive effect on cytotoxic T lymphocytes (CTL) as well as activates Treg cells to protect cancer cells.